Holdings in GSK
| Report Date |
Value (USD) |
Shares |
Change |
Type |
Discretion |
Filed |
| 2025-12-31 |
$131,413,517 |
2,679,721 |
+26.4%
|
Shares |
Sole |
2026-02-17 |
| 2025-09-30 |
$91,518,449 |
2,120,446 |
-5.4%
|
Shares |
Sole |
2025-11-14 |
| 2025-06-30 |
$86,107,699 |
2,242,388 |
-14.5%
|
Shares |
Sole |
2025-08-14 |
| 2025-03-31 |
$101,624,550 |
2,623,246 |
-28.4%
|
Shares |
Sole |
2025-05-15 |
| 2024-12-31 |
$123,840,993 |
3,661,768 |
-9.7%
|
Shares |
Sole |
2025-02-14 |
| 2024-09-30 |
$165,858,581 |
4,057,206 |
+17.0%
|
Shares |
Sole |
2024-11-14 |
| 2024-06-30 |
$133,521,080 |
3,468,080 |
-8.1%
|
Shares |
Sole |
2024-08-14 |
| 2024-03-31 |
$161,705,382 |
3,771,994 |
+26.9%
|
Shares |
Sole |
2024-05-15 |
| 2023-12-31 |
$110,177,675 |
2,972,954 |
-8.8%
|
Shares |
Sole |
2024-02-14 |
| 2023-09-30 |
$118,151,147 |
3,259,342 |
+13.1%
|
Shares |
Sole |
2023-11-14 |
| 2023-06-30 |
$102,679,267 |
2,881,012 |
-22.8%
|
Shares |
Sole |
2023-11-08 |
| 2023-03-31 |
$132,766,734 |
3,731,499 |
—
|
Shares |
Sole |
2023-11-08 |
